| Literature DB >> 35520490 |
Anupam Roy1, Onur Bulut2,3,4, Sudip Some5, Amit Kumar Mandal5, M Deniz Yilmaz4,6.
Abstract
Since discovery of the first antibiotic drug, penicillin, in 1928, a variety of antibiotic and antimicrobial agents have been developed and used for both human therapy and industrial applications. However, excess and uncontrolled use of antibiotic agents has caused a significant growth in the number of drug resistant pathogens. Novel therapeutic approaches replacing the inefficient antibiotics are in high demand to overcome increasing microbial multidrug resistance. In the recent years, ongoing research has focused on development of nano-scale objects as efficient antimicrobial therapies. Among the various nanoparticles, silver nanoparticles have gained much attention due to their unique antimicrobial properties. However, concerns about the synthesis of these materials such as use of precursor chemicals and toxic solvents, and generation of toxic byproducts have led to a new alternative approach, green synthesis. This eco-friendly technique incorporates use of biological agents, plants or microbial agents as reducing and capping agents. Silver nanoparticles synthesized by green chemistry offer a novel and potential alternative to chemically synthesized nanoparticles. In this review, we discuss the recent advances in green synthesis of silver nanoparticles, their application as antimicrobial agents and mechanism of antimicrobial mode of action. This journal is © The Royal Society of Chemistry.Entities:
Year: 2019 PMID: 35520490 PMCID: PMC9059941 DOI: 10.1039/c8ra08982e
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 4.036
Fig. 1Schematic representation of the procedure for green synthesis of silver nanoparticles using various biological entities.
Antimicrobial activity of green synthesized silver nanoparticles using various biological materials including plants, algae, bacteria, fungi and yeasts
| Biological entity | Size and morphology | Test microorganism | Method | Comment | Reference |
|---|---|---|---|---|---|
|
| |||||
|
| 37 nm; spherical |
| Agar well diffusion method | 16–24 mm and 11–12 mm zones of inhibition against the tested bacterial and fungal strains, respectively |
|
| Green and black tea | 10–20 nm; spherical | Methicillin- and vancomycin-resistant | Disk diffusion and broth dilution methods | 19–21 mm inhibition zones, and MIC = 8 μg ml−1 |
|
|
| 30–42 nm; flower-like |
| Disk diffusion method | 6–11 mm and 5–8 mm zones of inhibition against the tested bacterial and fungal strains, respectively |
|
|
| 27 nm; spherical |
| Disk diffusion method | 67.9% ( |
|
|
| 20–35 nm; spherical |
| Agar well diffusion method | 19–22 mm, 23–26 mm, 17–19 mm inhibition zones at 300 μg ml−1 concentration against Gram positive and negative bacteria, and fungi, respectively |
|
|
| 12.6 nm; quasi-spherical |
| Broth dilution method | MIC = 20 μg ml−1 for |
|
|
| 12.9 nm; quasi-spherical |
| Broth dilution method | MIC = 10 μg ml−1 for both |
|
|
| 28 nm; spherical |
| Disc diffusion and broth macro-dilution methods | 17 mm zone of inhibition against |
|
|
| 15–34 nm; spherical |
| Agar cup and broth micro-dilution methods | No zone of inhibition was observed against |
|
|
| 14.6 nm; spherical |
| Disc diffusion and broth dilution methods | Antibacterial activity of AgNPs bio-synthesized using the plant extract and pure bioactive compound was compared. Similar zones of inhibition (10 mm) and MICs (150 μg ml−1) were observed |
|
|
| Various sizes depending on the [metal]-to-[extract] ratio; spherical |
| Disc diffusion and broth dilution methods | Antibacterial activity of AgNPs was tested against both reference strains (10–14 mm zones of inhibition and MICs = 4.7–8.4 pM) and clinical isolates (13–15 mm zones of inhibition and MICs = 4.4–5.2 pM) |
|
|
| 19–30 nm; spherical |
| Agar well diffusion method | 12–15 mm zones of inhibition against all test microorganisms |
|
|
| 25–43 nm; spherical |
| Agar well diffusion method | 8–10 mm zones of inhibition were observed at the concentration of 100 μg ml−1 AgNPs |
|
|
| 10–150 nm; spherical |
| Disk diffusion method | Zones of inhibition at the highest concentration were 8.5–10.5 mm and 9–10 mm against the tested Gram negative and positive bacteria, respectively |
|
|
| 15 nm; spherical |
| Disk diffusion method | Bio-synthesized AgNPs were more effective against Gram negative bacteria than Gram positive bacteria. 19–21 mm zones of inhibition were observed against Gram negative bacteria, whereas it was 15–17 mm against Gram positive bacteria |
|
|
| 1.9–4.3 nm and 5–25 nm, with and without microwave treatment; spherical | ESBL producing, | Agar well diffusion and broth dilution methods | 19–21 mm zones of inhibition, MICs = 27–36 μg ml−1, and MBCs = 30–42 μg ml−1 were observed against all test microorganisms. Additionally, ∼80% inhibition of biofilms formed by |
|
|
| 23.7 nm; spherical |
| Agar well diffusion and broth dilution methods | MICs and MBCs of AgNPs were determined to be 1.7–6.8 μg ml−1 and 5.1–10.2 μg ml−1, respectively |
|
|
| 18 nm; spherical |
| Disk diffusion and broth micro-dilution methods | 19–28 mm inhibition zones at 300 μg ml−1 concentration, and MIC = 11–18 μg ml−1 |
|
|
| 25 nm; spherical | Fish pathogens: | Agar well diffusion method | MICs were determined to be 3.12 μg ml−1 ( |
|
|
| 4–50 nm; hexagonal and spherical | Plant pathogens: | Agar well diffusion method | AgNPs bio-synthesized using leaf and stem extracts of the plant were compared. Both yielded similar zones of inhibition (8–9 mm) against the pathogens. AgNP-chloramphenicol combination further increased the activity |
|
|
| 55–83 nm; spherical | MDR clinical isolates of | Disk diffusion method | Dose-dependent activity of AgNPs was observed. 11–18 mm zones of inhibition against all isolates at the highest concentration |
|
|
| |||||
|
| |||||
|
| 66.3 nm and 81.8 nm; cubic |
| Direct contact test | Biosynthesized AgNPs-polysulfone composite material suppressed the growth of all tested bacteria |
|
|
| 10 nm; spherical–ellipsoidal |
| Agar well diffusion method | 14–21 mm zones of inhibition against all tested bacteria |
|
|
| 4–24 nm; spherical |
| Agar well diffusion method | 10.5–12 mm and 9.2–10.2 mm zones of inhibitions against bacterial and fungal strains, respectively |
|
|
| 35 nm; quasi-spheres |
| Agar well diffusion and broth macro-dilution methods | 11–20 mm zones of inhibition, MICs = 0.25–0.50 mg ml−1, and MBCs = 0.50–1 mg ml−1 |
|
|
| 10 nm; spherical |
| Agar well diffusion method | Dose dependent antimicrobial activity was observed. 12–14 mm zones of inhibition at the highest concentration |
|
|
| 2–15 nm; spherical |
| Agar well diffusion method | The highest antibacterial activities were measured as 15–23% inhibition in the cases of |
|
|
| 2–32 nm; spherical |
| Disk diffusion and broth dilution methods | The antimicrobial activity of bio-synthesized AgNPs were compared to chemically synthesized AgNPs. Bio-synthesized AgNPs exhibited high antimicrobial activity (expect for |
|
|
| |||||
|
| 22–60 nm; spherical |
| Agar bioassay and disk diffusion methods | At 100 μg ml−1 concentration, 18 mm inhibition zone and complete inhibition of |
|
|
| 14.77 nm; spherical |
| Agar well diffusion and broth dilution methods | High antimicrobial activity except for |
|
|
| 43 nm; spherical |
| Agar well diffusion method and MTT assay | ∼12 mm zones of inhibition and EC50 = 15–16 μg ml−1 against the tested bacteria |
|
|
| N.A.; spherical and ellipsoidal | Clinical isolates of | Disk diffusion method | Dose-dependent antifungal activity; 11–18 mm and 13–22 mm zones of inhibitions at the lowest and highest concentrations, respectively |
|
|
| 15–35 nm; spherical |
| Tested on cotton fabrics | Cotton fabrics treated with bio-synthesized AgNPs exhibited high antimicrobial activity. However, it decreased by increasing number of washing cycles |
|
|
| 20 nm; spherical |
| Disk diffusion method | 14–18 mm zones of inhibition against all test microorganisms |
|
|
| |||||
|
| 27–54 nm; spherical |
| Anti-microfouling assay | At the highest concentration, up to 99% reduction of microfouling |
|
|
| 5–50 nm; spherical |
| Disk diffusion method | At the highest concentration, AgNPs exhibited higher antimicrobial activity than the standard drug streptomycin; 21–26 mm zones of inhibition |
|
|
| 20.2–94.9 nm; spherical |
| Broth micro-dilution method | Effects of pH and extract concentrations were tested. At the optimum conditions, MICs were 34.3 μM and 81.2 μM for |
|
|
| 33–81 nm; cubic |
| Disk diffusion method | 18.75–23.5 mm zones of inhibition |
|
|
| 60–200 nm; spherical |
| Agar well diffusion method | 20–40 mm zones of inhibition; high antibacterial activity against |
|
|
| 18–46 nm; spherical |
| Disk diffusion method | 12 and 11 mm zones of inhibition against |
|
|
| 7–18 nm and 5–20 nm; spherical |
| Tested on cotton fabrics | Cotton fabrics treated with bio-synthesized AgNPs exhibited high antimicrobial activity. However, it decreased by increasing number of washing cycles |
|
|
| 13 nm; spherical |
| Broth dilution method | 100% and 60% inhibition of growth at 5 μg ml−1 and 15 μg ml−1 for |
|
|
| |||||
|
| 51–100 nm; spherical |
| Agar well diffusion method | 23–25 mm zones of inhibition against the bacterial strains, poor antifungal activity |
|
|
| 140 nm; spherical |
| Growth kinetic monitoring | In the presence of bio-synthesized AgNPs, growth rates of the test strains were significantly reduced |
|
|
| 24.13 nm; irregular |
| Agar well diffusion method | 16–20 mm and 16–22 mm zones of inhibitions against tested Gram positive and negative bacteria, respectively |
|
|
| 31.86 nm; elongated |
| Agar well diffusion method | No antimicrobial activity |
|
|
| 14.64 nm; irregular |
| Agar well diffusion method | 14–18 mm and 15–20 mm zones of inhibitions against tested Gram positive and negative bacteria, respectively |
|
|
| 10–50 nm; spherical | Clinical isolates of MDR | Disk diffusion method | Dose-dependent antimicrobial activity; 17–18 mm and 33–36 mm zones of inhibitions at the lowest and highest concentrations, respectively |
|
|
| 15–54 nm; spherical |
| Broth dilution method | MIC = 0.012 mg ml−1 and MBC = 0.016 mg ml−1 for |
|
|
| |||||
|
| 10–15 nm; spherical | MDR | Agar well diffusion and broth micro-dilution methods | 21.2 mm zone of inhibition, MIC = 15.62 μg ml−1, and MBC = 31.24 μg ml−1 |
|
|
| 4–30 nm; spherical | Methicillin resistant | Disk diffusion method | More effective against tested Gram negative strains; at the highest concentration, 12–23 mm and 34–36 mm zones of inhibition against Gram positive and negative strains, respectively |
|
|
| 4–55 nm; spherical |
| Disk diffusion method | 12–16 mm and 18 mm zones of inhibition against bacterial and fungal strains, respectively |
|
|
| 10–40 nm; spherical |
| Disk diffusion and broth micro-dilution methods | Bio-synthesized AgNPs lower than 100 μg did not exhibit any antimicrobial activity. 11–14 mm zones of inhibition at the highest concentration, MICs = 13.21–18.96 μg ml−1 |
|
|
| 2–83 nm; variable |
| Broth micro-dilution assay | At 50 μg ml−1 bio-synthesized Ag/AgCl NP concentration, 83–85% inhibition of growth was observed for the test strains |
|
|
| 35–400 nm; spherical | Phytopathogenic fungal strains: | Agar well diffusion and broth micro-dilution methods | 7.9–11.4 mm zones of inhibition, and MICs = 4 mg l−1 against all tested fungal strains |
|
|
| 15–220 nm; spherical | Phytopathogenic fungal strains: | Agar well diffusion and broth micro-dilution methods | 9.7–15.1 mm zones of inhibition, and MICs = 2 mg l−1 against all tested fungal strains |
|
|
| 15.5 nm; spherical |
| Broth micro-dilution method | High antifungal activity, especially against |
|
|
| 133 nm; spherical |
| Agar well diffusion method | 15–19 mm and 26–28 mm zones of inhibition against the tested Gram negative and positive bacteria, respectively |
|
|
| 5–50 nm; spherical | Fluconazole susceptible and resistant | Broth micro-dilution method | MICs for both susceptible and resistant strains were in the range of 2–4 μg ml−1 |
|
|
| 5–30 nm; spherical |
| Agar well diffusion and broth micro-dilution methods | Various pH conditions (4–10) were used to optimize the bio-synthesis of AgNPs with high antimicrobial activity. At optimum pH of 7.0, zones of inhibitions and MICs were 6–13 mm and 3.12–12.5 μg ml−1 against all test strains, respectively |
|
|
| 64.3 nm; spherical |
| Disk diffusion assay | The antibacterial activity of standard drugs was enhanced in the presence of bio-synthesized AgNPs. The highest fold increase was observed for erythromycin and carbenicillin against |
|
|
| 25 nm; spherical |
| Agar well diffusion method | 13–21 mm zones of inhibition against all test strains |
|
|
| |||||
|
| 34–90 nm; spherical and oval |
| Agar well diffusion method | More effective against Gram negative bacteria; 11–13 mm and 17–18 mm zones of inhibition in the cases of Gram positive and negative bacteria, respectively |
|
|
| 4.8–6.6 nm; spherical |
| Agar well diffusion method | 11–19 mm and 15 mm zones of inhibitions against the tested bacterial strains and fungal strain, respectively |
|
|
| 37–168 nm; spherical | MDR | Broth micro-dilution method | MICs = 1.56–3.125 μg ml−1 against all tested strains; additionally, bio-synthesized AgNPs reduced the bacterial attachment at the rate of 66–86% |
|
|
| 150 nm; spherical |
| Disk diffusion method | 12–26 mm and 25 mm zones of inhibitions against the tested bacterial strains and fungal strain, respectively. Additionally, 5–6 μg of bio-synthesized AgNPs significantly inhibited the biofilm formation |
|
|
| 10–30 nm; spherical |
| Live/dead bacterial viability fluorescence assay | Viability of the bacterium was reduced to 45% in the presence of 9.2 μg ml−1 bio-synthesized AgNPs |
|
|
| 127 nm; spherical |
| Agar well diffusion method | The antimicrobial activity was maximum for |
|
|
| 38–85 nm; spherical |
| Agar well diffusion method | 14–15 mm zones of inhibition against all test strains |
|
|
| 10–31 nm; spherical |
| Agar well diffusion method | Dose dependent antimicrobial activity; 10–14 mm and 13–18 mm zones of inhibition against all test strains at the lowest and highest concentrations, respectively |
|
|
| |||||
|
| 100 nm; spherical |
| Agar well diffusion and broth micro-dilution methods | 20–34 mm and 14–24 mm zones of inhibition against test bacterial and fungal strains respectively. MICs were determined to be 1.95 μM (MRSA), 1.95 μM ( |
|
|
| 121 nm; spherical |
| Agar well diffusion and broth micro-dilution methods | No antimicrobial activity against |
|
|
| 160 nm; spherical |
| Agar well diffusion and broth micro-dilution methods | 15–29 mm and 15–28 mm zones of inhibition against test bacterial and fungal strains respectively. MICs were determined to be 125 μM (MRSA), 62.5 μM ( |
|
|
| 8–48 nm; spherical |
| Disk diffusion and broth micro-dilution methods | 6–10 mm zones of inhibitions against the test strains (except for |
|
|
| 22–85 nm; spherical |
| Agar well diffusion method | Bio-synthesized AgNPs by one of the isolates exhibited the maximum zones of inhibition (16–19 mm) against all tested microorganisms. Synergistic effect of AgNPs with standard drugs was also observed |
|
|
| 20–45 nm; various |
| Agar well diffusion method | 16–20 mm zones of inhibition against all test strains |
|
|
| 30–90 nm; spherical |
| Agar well diffusion and broth micro-dilution methods | 22–33 mm and 23–28 mm zones of inhibition, MICs = 7–18 μg ml−1 and 13–18 μg ml−1 against tested bacterial and fungal strains, respectively |
|
|
| 10–40 nm; spherical |
| Agar well diffusion method | The highest zone of inhibition (36 mm) was observed in the case of |
|
Fig. 2Nitrate reductase mediated synthesis of AgNPs (this figure has been adapted from ref. 119 with permission from Springer).
Fig. 3Bactericidal effect of green synthesized AgNPs on different bacterial strains. Dose-dependent activity of AgNPs synthesized using Allophylus cobbe leaves. The bacterial strains were incubated at various AgNP concentrations ranging from 0.1 to 1.0 μg ml−1 and bacterial rate survival was estimated by colony forming unit (CFU) assay at 4 h (this figure has been adapted from ref. 22 with permission from Springer).
Fig. 4General mechanisms for antimicrobial mode of action of silver nanoparticles (this figure has been adapted from ref. 159 with permission from Frontiers).
Fig. 5Time-dependent TEM images of E. coli cells treated with biosynthesized AgNPs using Aspergillus niger extract. (a) The untreated cell; (b) adhesion of AgNPs on the E. coli cell wall at 1 h; (c) disruption of the cell membrane by formation of pits and gaps at 5 h; (d) complete disruption of the cell wall and membrane; (e) penetration of AgNPs into the E. coli cell at 8 h; (f) disintegration of the cell and cell lysis at 12 h (this figure has been adapted from ref. 176 with permission from Hindawi).
Fig. 6FE-SEM images of B. cereus, S. aureus, E. coli and P. aeruginosa cells untreated (A–D) and treated (E–H) with AgNPs. After 60 min of treatment with AgNPs biosynthesized using soil derived Pseudomonas putida, all cells were subjected to severe membrane damage (this figure has been adapted from ref. 164 with permission from Elsevier).
Fig. 7Agarose gel electrophoresis of biosynthesized AgNP-treated plasmid DNA. Lane 1, DNA marker. Lane 2, untreated plasmid DNA in supercoiled form. Lane 3, plasmid DNA treated with 0.51 μg of AgNPs showing a decrease in supercoiled DNA form. Lane 4, plasmid DNA treated with 1.02 μg of AgNPs. Lane 5, plasmid DNA treated with 2.55 μg of AgNPs. Lane 6 plasmid DNA treated with 0.51 μg of AgNPs showing degradation of DNA bands. Lane 7, plasmid DNA treated with 5.1 μg of AgNPs showing the highest degree of DNA degradation (this figure has been adapted from ref. 189 with permission from Springer).
Fig. 8Synergistic effect of biosynthesized AgNPs and standard antibiotic drugs on ROS generation. Results of ROS measurement after 12 h treatment of the bacterial cells with AgNPs alone, antibiotics alone, and combinations of AgNPs with antibiotics (this figure has been adapted from ref. 22 with permission from Springer).
Fig. 9(A) H2-DCFDA assay for investigation biosynthesized AgNP-induced intracellular ROS generation; (B) the dose-dependent ROS generation in AgNP-treated in E. coli and P. aeruginosa; (C) relative GSH concentration in the treated cells as compared to positive control (PC), 1 mM H2O2; (D) fluorescence microscopy images of untreated, AgNP-treated, and gentamicin-treated E. coli and P. aeruginosa cells. SYTO 9 (green fluorescent) stained cells are intact and live, while PI (red fluorescent) stained cells are dead due to disruption of the cell membrane. As control, gentamicin, a standard antibiotic drug known to cause cell membrane damage, treated cell also displayed red fluorescent colour (this figure has been adapted from ref. 168 with permission from American Chemical Society).